论文部分内容阅读
目的:探索盐酸氨溴索用于辅助治疗加重期慢性阻塞性肺病的临床疗效和推广价值。方法:针对本院从2011年3月至2013年3月的94例加重期慢性阻塞性肺病患者进行实验,将其随即分成两组,全部患者均采取常规性治疗(祛痰、吸氧、镇咳、解痉等治疗)其中观察组47人,在常规治疗的基础上,再给予盐酸氨溴索静脉注射治疗。对照组47人,仅仅采取常规治疗。比照两组患者的治疗效果和观察并发症情况,将数据进行通过统计学分析。结果:对照组47人,其中显效有35人,有效11人,无效1人,总治疗有效率达到了97.8%。对照组47人,其中显效24人,有效16人,无效7人,总治疗有效率达到了85.1%。两组比对有统计学差异。(P<0.05)。结论:采取静脉注射的给药方式对于加重期慢性阻塞性肺病患者的治疗效果有提高的作用,值得在临床上推广。
Objective: To explore the clinical efficacy and promotion value of ambroxol hydrochloride in adjuvant treatment of exacerbation of chronic obstructive pulmonary disease. Methods: A total of 94 patients with exacerbation of chronic obstructive pulmonary disease from March 2011 to March 2013 in our hospital were randomly divided into two groups. All patients received routine treatment (expectorant, oxygen inhalation, Cough, antispasmodic treatment), including 47 cases of observation group, on the basis of conventional treatment, and then given ambroxol hydrochloride intravenous injection. Control group of 47 people, only to take conventional treatment. The two groups of patients according to the treatment effect and observe the complications, the data through statistical analysis. Results: There were 47 patients in the control group, of which 35 were markedly effective, 11 were effective, 1 were ineffective, and the total effective rate was 97.8%. The control group of 47 people, of which 24 were markedly effective, effective 16, invalid 7, the total effective rate of treatment reached 85.1%. There was a significant difference between the two groups. (P <0.05). Conclusion: The intravenous injection mode of treatment for patients with exacerbation of chronic obstructive pulmonary disease have an improving effect, it is worth in the clinical promotion.